护理研究
護理研究
호리연구
NURSING RESEARCH
2015年
6期
667-670
,共4页
5A 干预法%伐尼克兰%COPD 稳定期%戒烟
5A 榦預法%伐尼剋蘭%COPD 穩定期%戒煙
5A 간예법%벌니극란%COPD 은정기%계연
5A intervention method%varenicline%stable phase of COPD%smoking cessation
[目的]研究5A 干预法联合伐尼克兰对 COPD 稳定期病人戒烟的效果。[方法]将300例 COPD 病人随机分为5A 戒烟组、伐尼克兰组和联合干预组，每组各100例。5A 戒烟组应用5A 干预法，伐尼克兰组给予口服伐尼克兰，联合干预组在口服伐尼克兰的基础上给予5A 干预法对病人进行戒烟干预，观察3组病人在实施戒烟后1个月、4个月、6个月的戒烟率、肺功能、住院率及生活质量的变化。[结果]联合干预组在干预后1个月、4个月、6个月病人的戒烟率、肺功能、住院率及生活质量明显高于5A 戒烟组和伐尼克兰组，差异有统计学意义(P <0.05)。[结论]采用5A 干预法联合伐尼克兰有利于提高 COPD 稳定期病人的戒烟率，改善肺功能，减少住院率，提高生活质量。
[目的]研究5A 榦預法聯閤伐尼剋蘭對 COPD 穩定期病人戒煙的效果。[方法]將300例 COPD 病人隨機分為5A 戒煙組、伐尼剋蘭組和聯閤榦預組，每組各100例。5A 戒煙組應用5A 榦預法，伐尼剋蘭組給予口服伐尼剋蘭，聯閤榦預組在口服伐尼剋蘭的基礎上給予5A 榦預法對病人進行戒煙榦預，觀察3組病人在實施戒煙後1箇月、4箇月、6箇月的戒煙率、肺功能、住院率及生活質量的變化。[結果]聯閤榦預組在榦預後1箇月、4箇月、6箇月病人的戒煙率、肺功能、住院率及生活質量明顯高于5A 戒煙組和伐尼剋蘭組，差異有統計學意義(P <0.05)。[結論]採用5A 榦預法聯閤伐尼剋蘭有利于提高 COPD 穩定期病人的戒煙率，改善肺功能，減少住院率，提高生活質量。
[목적]연구5A 간예법연합벌니극란대 COPD 은정기병인계연적효과。[방법]장300례 COPD 병인수궤분위5A 계연조、벌니극란조화연합간예조，매조각100례。5A 계연조응용5A 간예법，벌니극란조급여구복벌니극란，연합간예조재구복벌니극란적기출상급여5A 간예법대병인진행계연간예，관찰3조병인재실시계연후1개월、4개월、6개월적계연솔、폐공능、주원솔급생활질량적변화。[결과]연합간예조재간예후1개월、4개월、6개월병인적계연솔、폐공능、주원솔급생활질량명현고우5A 계연조화벌니극란조，차이유통계학의의(P <0.05)。[결론]채용5A 간예법연합벌니극란유리우제고 COPD 은정기병인적계연솔，개선폐공능，감소주원솔，제고생활질량。
Objective:To study the effect of 5A intervention method combined with varenicline for smoking ces-sation of COPD patients in stable stage.Methods:A total of 300 cases of COPD patients were randomly divided into 5A smoking cessation group,varenicline group and combined intervention group,100 cases in each.Patients in 5A smoking cessation group applied 5A intervention method,patients in varenicline group were given oral varenicline,patients in combined intervention group were given 5A intervention on the basis of the oral vareni-cline,then to observe the changes in lung function,smoking cessation rate,hospitalization rate and quality of life of three groups of patients respectively after 1 months,4 months and 6 months after quit smoking.Results:Smoking cessation rates,lung function,hospitalization rate and quality of life of patients in combined interven-tion group were higher than that of 5A group and varenicline group in 1 month,4 months,6 months after the in-tervention,and the difference was statistically significant (P <0.05).Conclusion:Using 5A intervention com-bined with varenicline is helpful to improve the smoking cessation rate of COPD patients in stable stage,im-prove lung function,reduce hospitalization rate and improve their quality of life.
